2m 2m 2m 2m 2m 2m 2m
GSK Sp ADR (GSK)
NYSE
$50.79+$0.19 (+0.37%)
Price as of Nov 12, 2026 8:12 AM EST- $101.4BMarket Cap
- 9.00%1-Year Change
- Drug Manufacturers - GeneralIndustry
GSK Sp ADR (GSK)
$50.79+$0.19 (+0.37%)
Earnings Score
Valuation | GSK | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | 1 | ||
Growth | -0 | ||
Low Earnings Volatility | N/A |
Momentum Score
Valuation | GSK | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -8.28% | ||
12-Month Momentum | -1.03% | ||
3-Month Risk Adjusted Momentum | -85.11% | ||
12-Month Risk Adjusted Momentum | -4.23% |
True Yield
Valuation | GSK | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | 3.56% | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | -0.82% |
Financial Health Score
Valuation | GSK | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 11 |